Litcius/Paper detail

JUPITER-06 establishes immune checkpoint inhibitors as essential first-line drugs for the treatment of advanced esophageal squamous cell carcinoma

Shun Yamamoto, Ken Kato

2022Cancer Cell24 citationsDOIOpen Access PDF

Topics & Concepts

ChemotherapyCancer researchEsophageal squamous cell carcinomaMedicineOncologyCarcinomaImmune checkpointImmune systemInternal medicineImmunotherapyImmunologyEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
JUPITER-06 establishes immune checkpoint inhibitors as essential first-line drugs for the treatment of advanced esophageal squamous cell carcinoma | Litcius